CORMORANT ASSET MANAGEMENT, LP – Prometheus Biosciences, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$116.79M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+109.03%
quarter
Prometheus Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.46% | -50K shares | 59.50M | $59.01 | 1.97M |
| Q2 2022 | share | Increase | +11.28% | 205.71K shares | -11.57M | $28.23 | 2.02M |
| Q1 2022 | share | Decrease | -1.33% | -24.58K shares | -4.21M | $37.76 | 1.82M |
| Q4 2021 | share | 0.00% | 0 shares | 29.25M | $37.87 | 1.84M | |
| Q3 2021 | share | 0.00% | 0 shares | -663K | $23.71 | 1.84M | |
| Q2 2021 | share | Decrease | -11.92% | -250K shares | 7.85M | $24.56 | 1.84M |
| Q1 2021 | share | Increase | 0.00% | 2.09M shares | 36.62M | $18.26 | 2.09M |